Selepressin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSelepressin
Drug Alias Nameselepressinum塞来加压素selepresina塞立加压素FE-202158
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1a receptor agonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFerring Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFerring Bv
Active IndicationsN/A
Inactive IndicationsShock, Septic

Other Information

ATC CodeN/A
Related LinksWikipedia